Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Return on Equity (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Return on Equity for 16 consecutive years, with 0.02% as the latest value for Q1 2026.

  • Quarterly Return on Equity fell 6.0% to 0.02% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.02% through Jan 2026, down 6.0% year-over-year, with the annual reading at 0.02% for FY2026, 6.0% down from the prior year.
  • Return on Equity for Q1 2026 was 0.02% at Usana Health Sciences, down from 0.03% in the prior quarter.
  • The five-year high for Return on Equity was 0.22% in Q1 2022, with the low at 0.02% in Q1 2026.
  • Average Return on Equity over 5 years is 0.12%, with a median of 0.12% recorded in 2024.
  • The sharpest move saw Return on Equity fell -12bps in 2022, then increased 3bps in 2023.
  • Over 5 years, Return on Equity stood at 0.19% in 2022, then fell by -30bps to 0.13% in 2023, then crashed by -40bps to 0.08% in 2024, then tumbled by -58bps to 0.03% in 2025, then tumbled by -35bps to 0.02% in 2026.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.02%, 0.03%, and 0.07% for Q1 2026, Q3 2025, and Q2 2025 respectively.